ACP-204

Drug identity checked against registry records

Also recorded as ACP-204 Tartrate

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia PsychosisNCT07029581ACADPhase 2Recruiting2028-02Estimated
ACP-204 in Adults With Alzheimer's Disease PsychosisNCT06159673ACADPhase 2, Phase 3Recruiting2028-01Estimated
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia PsychosisNCT07095465ACADPhase 3Recruiting2029-02Estimated
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension StudyNCT06194799ACADPhase 3Enrolling by invitation2029-04Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.